Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 1 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 163Recruiting 73Terminated 59Unknown 33Active not recruiting 29Not yet recruiting 13Withdrawn 10Suspended 2Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3Glioma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenoviridae Infections 2Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms 1Multiple Myeloma 1Metastatic Castration-resistant Prostate Cancer 1Mesothelioma, Malignant 1Melanoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Graft vs Host Disease 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Esophageal Squamous Cell Carcinoma 1Epstein-Barr Virus Infections 1Cytomegalovirus Infections 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Enrolling by invitation × Prostatic Neoplasms × Clear all
NCT04145375 2026-05-08

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Zenith Epigenetics

Phase 1/2 Enrolling by invitation
40 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡